Structure

Physi-Chem Properties

Molecular Weight:  512.24
Volume:  536.984
LogP:  7.155
LogD:  2.63
LogS:  -3.39
# Rotatable Bonds:  10
TPSA:  133.52
# H-Bond Aceptor:  8
# H-Bond Donor:  4
# Rings:  2
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.241
Synthetic Accessibility Score:  3.315
Fsp3:  0.379
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.368
MDCK Permeability:  1.1071552762587089e-05
Pgp-inhibitor:  0.793
Pgp-substrate:  0.981
Human Intestinal Absorption (HIA):  0.4
20% Bioavailability (F20%):  0.933
30% Bioavailability (F30%):  0.007

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.001
Plasma Protein Binding (PPB):  89.88729095458984%
Volume Distribution (VD):  0.645
Pgp-substrate:  11.19440746307373%

ADMET: Metabolism

CYP1A2-inhibitor:  0.091
CYP1A2-substrate:  0.81
CYP2C19-inhibitor:  0.619
CYP2C19-substrate:  0.231
CYP2C9-inhibitor:  0.715
CYP2C9-substrate:  0.917
CYP2D6-inhibitor:  0.028
CYP2D6-substrate:  0.183
CYP3A4-inhibitor:  0.141
CYP3A4-substrate:  0.219

ADMET: Excretion

Clearance (CL):  6.609
Half-life (T1/2):  0.121

ADMET: Toxicity

hERG Blockers:  0.004
Human Hepatotoxicity (H-HT):  0.782
Drug-inuced Liver Injury (DILI):  0.899
AMES Toxicity:  0.017
Rat Oral Acute Toxicity:  0.201
Maximum Recommended Daily Dose:  0.046
Skin Sensitization:  0.93
Carcinogencity:  0.044
Eye Corrosion:  0.003
Eye Irritation:  0.811
Respiratory Toxicity:  0.262

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC16197

Natural Product ID:  NPC16197
Common Name*:   Mallotojaponin C
IUPAC Name:   1-[3-[[3-acetyl-2,4-dihydroxy-6-methoxy-5-(3-methylbut-2-enyl)phenyl]methyl]-2,6-dihydroxy-4-methoxy-5-(3-methylbut-2-enyl)phenyl]ethanone
Synonyms:   Mallotojaponin C
Standard InCHIKey:  SQDDGCHCPZMCOU-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C29H36O8/c1-14(2)9-11-18-24(32)22(16(5)30)26(34)20(28(18)36-7)13-21-27(35)23(17(6)31)25(33)19(29(21)37-8)12-10-15(3)4/h9-10,32-35H,11-13H2,1-8H3
SMILES:  COc1c(Cc2c(OC)c(CC=C(C)C)c(c(c2O)C(=O)C)O)c(O)c(c(c1CC=C(C)C)O)C(=O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2337125
PubChem CID:   71658103
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0002279] Benzene and substituted derivatives
        • [CHEMONTID:0000369] Diphenylmethanes

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32759 mallotus oppositifolius Species Euphorbiaceae Eukaryota n.a. Madagascar Dry Forest n.a. PMID[23286240]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT179 Cell Line A2780 Homo sapiens IC50 = 1300.0 nM PMID[506598]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC100 = 39.0 uM PMID[506598]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 70.0 nM PMID[506598]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 3600.0 nM PMID[506598]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum LD50 = 0.81 uM PMID[506598]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum LD50 = 0.8 uM PMID[506598]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 140.0 nM PMID[506598]
NPT1225 Organism Plasmodium falciparum (isolate FcB1 / Columbia) Plasmodium falciparum FcB1/Columbia IC50 = 750.0 nM PMID[506599]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC16197 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9921 High Similarity NPC15834
0.9921 High Similarity NPC215875
0.9764 High Similarity NPC279566
0.9695 High Similarity NPC322301
0.9695 High Similarity NPC255801
0.9685 High Similarity NPC186628
0.9615 High Similarity NPC103842
0.9542 High Similarity NPC156092
0.9542 High Similarity NPC13575
0.947 High Similarity NPC249606
0.947 High Similarity NPC477243
0.947 High Similarity NPC66349
0.947 High Similarity NPC25287
0.947 High Similarity NPC186838
0.947 High Similarity NPC150399
0.947 High Similarity NPC98115
0.947 High Similarity NPC477244
0.947 High Similarity NPC12165
0.947 High Similarity NPC1486
0.947 High Similarity NPC477242
0.947 High Similarity NPC168105
0.947 High Similarity NPC41461
0.947 High Similarity NPC274109
0.9407 High Similarity NPC476508
0.9398 High Similarity NPC317119
0.9398 High Similarity NPC472419
0.9398 High Similarity NPC153979
0.9394 High Similarity NPC131039
0.9389 High Similarity NPC20560
0.9389 High Similarity NPC28753
0.9389 High Similarity NPC204960
0.9389 High Similarity NPC82225
0.9389 High Similarity NPC144051
0.9389 High Similarity NPC18877
0.9389 High Similarity NPC159623
0.9389 High Similarity NPC294593
0.9328 High Similarity NPC272844
0.9328 High Similarity NPC254168
0.9328 High Similarity NPC477056
0.9328 High Similarity NPC471620
0.9328 High Similarity NPC21350
0.9328 High Similarity NPC243528
0.9328 High Similarity NPC248995
0.9328 High Similarity NPC251681
0.9328 High Similarity NPC477055
0.9318 High Similarity NPC286336
0.9313 High Similarity NPC285054
0.9259 High Similarity NPC53181
0.9259 High Similarity NPC217186
0.9259 High Similarity NPC470211
0.9259 High Similarity NPC240305
0.9259 High Similarity NPC283429
0.9259 High Similarity NPC472366
0.9259 High Similarity NPC477956
0.9248 High Similarity NPC101752
0.9242 High Similarity NPC312318
0.9242 High Similarity NPC472365
0.9242 High Similarity NPC337373
0.9242 High Similarity NPC242294
0.9242 High Similarity NPC192304
0.9242 High Similarity NPC175098
0.9242 High Similarity NPC56031
0.9242 High Similarity NPC27643
0.9242 High Similarity NPC263670
0.9242 High Similarity NPC188646
0.9242 High Similarity NPC139813
0.9237 High Similarity NPC186097
0.9237 High Similarity NPC475009
0.9237 High Similarity NPC475008
0.9231 High Similarity NPC84772
0.9203 High Similarity NPC194949
0.9203 High Similarity NPC328623
0.9203 High Similarity NPC282957
0.9197 High Similarity NPC297600
0.9191 High Similarity NPC213659
0.9191 High Similarity NPC144118
0.9191 High Similarity NPC80962
0.9191 High Similarity NPC241100
0.9191 High Similarity NPC326109
0.9191 High Similarity NPC259166
0.9191 High Similarity NPC11056
0.9191 High Similarity NPC204985
0.9191 High Similarity NPC172250
0.9191 High Similarity NPC159275
0.9191 High Similarity NPC48624
0.9191 High Similarity NPC215311
0.9191 High Similarity NPC253822
0.9191 High Similarity NPC219917
0.9179 High Similarity NPC174999
0.9167 High Similarity NPC87231
0.9167 High Similarity NPC129132
0.9167 High Similarity NPC212631
0.9167 High Similarity NPC257756
0.9167 High Similarity NPC103105
0.9167 High Similarity NPC205468
0.916 High Similarity NPC250057
0.916 High Similarity NPC324482
0.9154 High Similarity NPC230818
0.913 High Similarity NPC185276
0.9124 High Similarity NPC470089
0.9124 High Similarity NPC258630
0.9124 High Similarity NPC469404
0.9124 High Similarity NPC110969
0.9124 High Similarity NPC321980
0.9124 High Similarity NPC55832
0.9124 High Similarity NPC470087
0.9124 High Similarity NPC279650
0.9124 High Similarity NPC268204
0.9124 High Similarity NPC156190
0.9124 High Similarity NPC248372
0.9124 High Similarity NPC110038
0.9124 High Similarity NPC26051
0.9124 High Similarity NPC17170
0.9124 High Similarity NPC166689
0.9124 High Similarity NPC282300
0.9124 High Similarity NPC52789
0.9124 High Similarity NPC96408
0.9124 High Similarity NPC26238
0.9118 High Similarity NPC18260
0.9118 High Similarity NPC78913
0.9118 High Similarity NPC55018
0.9118 High Similarity NPC295384
0.9118 High Similarity NPC301217
0.9118 High Similarity NPC303633
0.9118 High Similarity NPC96565
0.9118 High Similarity NPC216978
0.9118 High Similarity NPC220062
0.9091 High Similarity NPC164236
0.9091 High Similarity NPC313618
0.9091 High Similarity NPC27490
0.9091 High Similarity NPC66384
0.9091 High Similarity NPC64359
0.9091 High Similarity NPC262359
0.9091 High Similarity NPC112192
0.9091 High Similarity NPC308037
0.9091 High Similarity NPC309717
0.9091 High Similarity NPC189106
0.9091 High Similarity NPC128348
0.9065 High Similarity NPC235217
0.9065 High Similarity NPC473014
0.9065 High Similarity NPC197252
0.9065 High Similarity NPC236766
0.9058 High Similarity NPC324134
0.9058 High Similarity NPC296917
0.9058 High Similarity NPC64915
0.9058 High Similarity NPC40833
0.9058 High Similarity NPC78
0.9058 High Similarity NPC166934
0.9058 High Similarity NPC161506
0.9058 High Similarity NPC166482
0.9058 High Similarity NPC37496
0.9058 High Similarity NPC1089
0.9058 High Similarity NPC148757
0.9058 High Similarity NPC227579
0.9058 High Similarity NPC76338
0.9058 High Similarity NPC325346
0.9058 High Similarity NPC220998
0.9058 High Similarity NPC76372
0.9058 High Similarity NPC11561
0.9058 High Similarity NPC32739
0.9058 High Similarity NPC265040
0.9058 High Similarity NPC177354
0.9058 High Similarity NPC10937
0.9058 High Similarity NPC266725
0.9058 High Similarity NPC194432
0.9058 High Similarity NPC324436
0.9058 High Similarity NPC223500
0.9058 High Similarity NPC66515
0.9058 High Similarity NPC226636
0.9058 High Similarity NPC328164
0.9058 High Similarity NPC182852
0.9058 High Similarity NPC228504
0.9058 High Similarity NPC306829
0.9058 High Similarity NPC167624
0.9058 High Similarity NPC107572
0.9058 High Similarity NPC125855
0.9051 High Similarity NPC150522
0.9051 High Similarity NPC261227
0.9051 High Similarity NPC69769
0.9051 High Similarity NPC101366
0.9051 High Similarity NPC172986
0.9051 High Similarity NPC471587
0.9051 High Similarity NPC265178
0.9051 High Similarity NPC270883
0.9044 High Similarity NPC470083
0.9044 High Similarity NPC219584
0.9044 High Similarity NPC124269
0.9044 High Similarity NPC201395
0.9044 High Similarity NPC472368
0.9044 High Similarity NPC131130
0.9037 High Similarity NPC476333
0.9037 High Similarity NPC156910
0.9037 High Similarity NPC473391
0.9037 High Similarity NPC472364
0.9037 High Similarity NPC213603
0.9037 High Similarity NPC24394
0.9037 High Similarity NPC472367
0.903 High Similarity NPC164136
0.903 High Similarity NPC125920
0.9008 High Similarity NPC69235

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC16197 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9242 High Similarity NPD6651 Approved
0.9091 High Similarity NPD1240 Approved
0.8955 High Similarity NPD1607 Approved
0.8929 High Similarity NPD4378 Clinical (unspecified phase)
0.8929 High Similarity NPD7410 Clinical (unspecified phase)
0.8824 High Similarity NPD1510 Phase 2
0.8696 High Similarity NPD1550 Clinical (unspecified phase)
0.8696 High Similarity NPD1552 Clinical (unspecified phase)
0.8639 High Similarity NPD8443 Clinical (unspecified phase)
0.8633 High Similarity NPD1549 Phase 2
0.8621 High Similarity NPD4380 Phase 2
0.8571 High Similarity NPD2800 Approved
0.8562 High Similarity NPD7411 Suspended
0.8523 High Similarity NPD7075 Discontinued
0.8446 Intermediate Similarity NPD7819 Suspended
0.8446 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8403 Intermediate Similarity NPD2532 Approved
0.8403 Intermediate Similarity NPD2534 Approved
0.8403 Intermediate Similarity NPD2533 Approved
0.8357 Intermediate Similarity NPD2796 Approved
0.8322 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8255 Intermediate Similarity NPD6801 Discontinued
0.8239 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8227 Intermediate Similarity NPD2935 Discontinued
0.8207 Intermediate Similarity NPD6799 Approved
0.8141 Intermediate Similarity NPD7473 Discontinued
0.8133 Intermediate Similarity NPD1934 Approved
0.8117 Intermediate Similarity NPD6959 Discontinued
0.8116 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.8092 Intermediate Similarity NPD7768 Phase 2
0.8082 Intermediate Similarity NPD1511 Approved
0.8079 Intermediate Similarity NPD2801 Approved
0.8077 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8065 Intermediate Similarity NPD6232 Discontinued
0.8056 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.8039 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8038 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD6599 Discontinued
0.7974 Intermediate Similarity NPD3882 Suspended
0.7973 Intermediate Similarity NPD1512 Approved
0.7931 Intermediate Similarity NPD1243 Approved
0.7902 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7877 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7877 Intermediate Similarity NPD3750 Approved
0.7848 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7848 Intermediate Similarity NPD6166 Phase 2
0.7848 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7847 Intermediate Similarity NPD1551 Phase 2
0.7838 Intermediate Similarity NPD7390 Discontinued
0.7826 Intermediate Similarity NPD5953 Discontinued
0.7812 Intermediate Similarity NPD7286 Phase 2
0.7808 Intermediate Similarity NPD2654 Approved
0.7792 Intermediate Similarity NPD3817 Phase 2
0.7778 Intermediate Similarity NPD2799 Discontinued
0.7764 Intermediate Similarity NPD7074 Phase 3
0.7746 Intermediate Similarity NPD943 Approved
0.7722 Intermediate Similarity NPD5710 Approved
0.7722 Intermediate Similarity NPD5711 Approved
0.7714 Intermediate Similarity NPD6832 Phase 2
0.7702 Intermediate Similarity NPD7054 Approved
0.7692 Intermediate Similarity NPD3749 Approved
0.7682 Intermediate Similarity NPD5403 Approved
0.7682 Intermediate Similarity NPD920 Approved
0.7671 Intermediate Similarity NPD2344 Approved
0.7654 Intermediate Similarity NPD7472 Approved
0.7651 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.764 Intermediate Similarity NPD3818 Discontinued
0.7628 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7626 Intermediate Similarity NPD1203 Approved
0.7622 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7606 Intermediate Similarity NPD2313 Discontinued
0.7603 Intermediate Similarity NPD6099 Approved
0.7603 Intermediate Similarity NPD6100 Approved
0.7595 Intermediate Similarity NPD5494 Approved
0.7571 Intermediate Similarity NPD2798 Approved
0.7561 Intermediate Similarity NPD7251 Discontinued
0.7561 Intermediate Similarity NPD6559 Discontinued
0.755 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.755 Intermediate Similarity NPD5401 Approved
0.7536 Intermediate Similarity NPD3972 Approved
0.7534 Intermediate Similarity NPD3748 Approved
0.7515 Intermediate Similarity NPD7808 Phase 3
0.75 Intermediate Similarity NPD6797 Phase 2
0.7483 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7468 Intermediate Similarity NPD3226 Approved
0.7467 Intermediate Similarity NPD2309 Approved
0.7451 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7448 Intermediate Similarity NPD5124 Phase 1
0.7448 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.741 Intermediate Similarity NPD9717 Approved
0.7407 Intermediate Similarity NPD9493 Approved
0.74 Intermediate Similarity NPD4628 Phase 3
0.74 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7372 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7361 Intermediate Similarity NPD3268 Approved
0.7355 Intermediate Similarity NPD7458 Discontinued
0.7346 Intermediate Similarity NPD3926 Phase 2
0.7343 Intermediate Similarity NPD4908 Phase 1
0.7342 Intermediate Similarity NPD5402 Approved
0.7338 Intermediate Similarity NPD422 Phase 1
0.7338 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7315 Intermediate Similarity NPD2346 Discontinued
0.7312 Intermediate Similarity NPD919 Approved
0.7305 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7299 Intermediate Similarity NPD9545 Approved
0.7299 Intermediate Similarity NPD1548 Phase 1
0.7299 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7297 Intermediate Similarity NPD7033 Discontinued
0.7273 Intermediate Similarity NPD5844 Phase 1
0.7261 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7254 Intermediate Similarity NPD1164 Approved
0.7254 Intermediate Similarity NPD2797 Approved
0.7248 Intermediate Similarity NPD5404 Approved
0.7248 Intermediate Similarity NPD5408 Approved
0.7248 Intermediate Similarity NPD5405 Approved
0.7248 Intermediate Similarity NPD5406 Approved
0.7229 Intermediate Similarity NPD1729 Discontinued
0.7222 Intermediate Similarity NPD1247 Approved
0.7214 Intermediate Similarity NPD1610 Phase 2
0.7214 Intermediate Similarity NPD1201 Approved
0.7211 Intermediate Similarity NPD230 Phase 1
0.7186 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7184 Intermediate Similarity NPD4360 Phase 2
0.7184 Intermediate Similarity NPD4363 Phase 3
0.7171 Intermediate Similarity NPD7003 Approved
0.717 Intermediate Similarity NPD1465 Phase 2
0.7168 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD4361 Phase 2
0.7133 Intermediate Similarity NPD1470 Approved
0.7079 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7067 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7067 Intermediate Similarity NPD4308 Phase 3
0.7063 Intermediate Similarity NPD3225 Approved
0.7063 Intermediate Similarity NPD1876 Approved
0.7055 Intermediate Similarity NPD4625 Phase 3
0.7055 Intermediate Similarity NPD3027 Phase 3
0.7042 Intermediate Similarity NPD1608 Approved
0.7041 Intermediate Similarity NPD6104 Discontinued
0.7032 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7014 Intermediate Similarity NPD3266 Approved
0.7014 Intermediate Similarity NPD3267 Approved
0.7007 Intermediate Similarity NPD1296 Phase 2
0.7007 Intermediate Similarity NPD3764 Approved
0.7 Intermediate Similarity NPD1651 Approved
0.7 Intermediate Similarity NPD37 Approved
0.6987 Remote Similarity NPD7422 Clinical (unspecified phase)
0.698 Remote Similarity NPD1933 Approved
0.698 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6974 Remote Similarity NPD2343 Clinical (unspecified phase)
0.697 Remote Similarity NPD7229 Phase 3
0.6966 Remote Similarity NPD6917 Clinical (unspecified phase)
0.6954 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6944 Remote Similarity NPD1283 Approved
0.6943 Remote Similarity NPD5049 Phase 3
0.694 Remote Similarity NPD7584 Approved
0.6937 Remote Similarity NPD5889 Approved
0.6937 Remote Similarity NPD5890 Approved
0.6934 Remote Similarity NPD1241 Discontinued
0.6918 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6914 Remote Similarity NPD2296 Approved
0.6914 Remote Similarity NPD4288 Approved
0.6905 Remote Similarity NPD7893 Clinical (unspecified phase)
0.6901 Remote Similarity NPD3847 Discontinued
0.6892 Remote Similarity NPD411 Approved
0.6892 Remote Similarity NPD6410 Clinical (unspecified phase)
0.6892 Remote Similarity NPD6798 Discontinued
0.689 Remote Similarity NPD6234 Discontinued
0.6886 Remote Similarity NPD7784 Clinical (unspecified phase)
0.6886 Remote Similarity NPD2403 Approved
0.6879 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6875 Remote Similarity NPD4749 Approved
0.6875 Remote Similarity NPD6585 Discontinued
0.6875 Remote Similarity NPD3600 Clinical (unspecified phase)
0.6875 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6871 Remote Similarity NPD4966 Approved
0.6871 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6871 Remote Similarity NPD4967 Phase 2
0.6871 Remote Similarity NPD4965 Approved
0.687 Remote Similarity NPD940 Approved
0.687 Remote Similarity NPD846 Approved
0.6867 Remote Similarity NPD6355 Discontinued
0.6867 Remote Similarity NPD447 Suspended
0.6865 Remote Similarity NPD8151 Discontinued
0.6863 Remote Similarity NPD1471 Phase 3
0.686 Remote Similarity NPD8312 Approved
0.686 Remote Similarity NPD8313 Approved
0.6857 Remote Similarity NPD4287 Approved
0.6849 Remote Similarity NPD1019 Discontinued
0.6831 Remote Similarity NPD4626 Approved
0.6831 Remote Similarity NPD17 Approved
0.6815 Remote Similarity NPD9266 Approved
0.6815 Remote Similarity NPD74 Approved
0.6813 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6809 Remote Similarity NPD1894 Discontinued
0.6807 Remote Similarity NPD7199 Phase 2
0.6806 Remote Similarity NPD1481 Phase 2
0.6803 Remote Similarity NPD9494 Approved
0.6803 Remote Similarity NPD3018 Phase 2
0.68 Remote Similarity NPD1612 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data